IFN-γ released from CD8+ T cells downregulates the expression of SLC7A11/SLC3A2 by activating the JAK/STAT pathway, which promotes tumor ferroptosis, contributing to the antitumor efficacy of immunotherapy [308, 309]. The gene discussed is SLC3A2; the disease is neoplasm.